rheumatoid arthritis

April 24, 2017April 24, 2017

Early Treatment Improves Rheumatoid Arthritis Symptoms, Helps Patients Live Longer, Study Suggests

Earlier and more aggressive treatment of rheumatoid arthritis (RA) helps patients grip things, walk and dress themselves better — and live longer, a study suggests. The daily lives of people ... Read more

April 19, 2017April 19, 2017

Inmedix, Omegawave to Adapt Elite-athlete Tests to Rheumatoid Arthritis Diagnosis

News, rheumatoid arthritis

Inmedix and Omegawave will work together on medical applications of tests related to athletes’ performance, with one target being rheumatoid arthritis (RA). A key goal will be to enhance biomarker evaluation ... Read more

April 17, 2017April 19, 2017

FDA Asks More Information a Second Time on Baricitinib as Arthritis Therapy

News, rheumatoid arthritis

U.S. regulators want additional dosing- and safety-related information before they will approve Eli Lilly and Incyte‘s New Drug Application (NDA) request for the rheumatoid arthritis (RA) treatment baricitinib. It is the second ... Read more

April 12, 2017April 12, 2017

Obesity May Alter Diagnosis, Management of RA When Blood Tests Are Used

News, rheumatoid arthritis

Obesity in women may interfere with the diagnosis and monitoring of rheumatoid arthritis (RA) through blood tests, according to a new study. Researchers call for more attention to the obesity ... Read more

April 7, 2017April 7, 2017

Half of RA Patients Stop Long-Term Anti-TNF Treatment; Decreased Effectiveness is Main Reason

News, rheumatoid arthritis

Rheumatoid arthritis (RA) patients discontinue long treatments with anti-TNF therapies mainly because the drug therapies lose effectiveness, according to a new study. The results, which included data from 123 patients ... Read more

April 5, 2017April 5, 2017

Review Updates Different Treatment Strategies for Rheumatoid Arthritis

News, rheumatoid arthritis

A new literature review updated the information on the effectiveness and safety of different classes of treatment strategies for rheumatoid arthritis (RA). The study, “Efficacy of glucocorticoids, conventional and targeted ... Read more

April 3, 2017April 3, 2017

Moderate Alcohol Consumption in RA Patients Taking Methotrexate May Not Be So Dangerous, Study Suggests

News, rheumatoid arthritis

Moderate weekly alcohol consumption in rheumatoid arthritis (RA) patients who take methotrexate (MTX) therapy may not be as dangerous as previously suggested, according to new research. The study, “Quantifying the ... Read more

March 31, 2017March 31, 2017

European Commission Approves Xeljanz to Treat Moderate to Severe Rheumatoid Arthritis

News, rheumatoid arthritis

Doctors in the European Union’s 28 member countries may now prescribe Pfizer’s Xeljanz (tofacitinib citrate) to treat adults with moderate to severe active rheumatoid arthritis (RA). The European Commission (EC) ... Read more

March 29, 2017March 29, 2017

Europe OKs Amgevita for Treating Rheumatoid Arthritis and Other Inflammatory Diseases

News, rheumatoid arthritis

Amgen’s Amgevita, a biosimilar to AbbVie’s Humira (adalimumab), has received European Union approval for treating rheumatoid arthritis (RA) and other inflammatory diseases. The U.S. Food and Drug Administration approved the medicine, under the name ... Read more

March 27, 2017March 27, 2017

Antibodies Against Collagen II Protein May Predict Good Prognosis in RA Patients

News, rheumatoid arthritis

Antibodies against a protein called collagen II may be associated with a good prognosis in patients with rheumatoid arthritis (RA), according to the results of a recent study. The study, ... Read more